Church Pandemic Resources

Referrals of Suspected CJD; CJD Cases; CJD Cases Reported by Province; Incidence of CJD - Cases Reported to CJD-SS in Canada

The second wave of H1N1 has tapered off and the number of doses of H1N1 vaccines being administered has declined. Consequently, the next issue of the Vaccine Surveillance Report will be posted the first week of March.

The Public Health Agency of Canada (PHAC) and Health Canada, with the collaboration of provinces and territories, the Canadian Paediatric Society and a network of researchers are actively monitoring adverse events following immunization to the H1N1 flu vaccine in Canada.

The National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. The Public Health Agency of Canada acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes.

In 2006, the first quadrivalent meningococcal conjugate vaccine (Menactra™) was authorized for use in Canada. This statement provides the evidence based analysis needed for consideration of this vaccine for immunization program planning by provinces and territories.

The Public Health Agency of Canada (PHAC) is committed to sharing information about H1N1 flu virus cases with Canadians.

The Government of Canada today announced it will make a donation of five million doses of the H1N1 flu vaccine, as well as a $6 million contribution to support the World Health Organization’s (WHO) global pandemic relief efforts.

As we move into a New Year, the second wave of the H1N1 flu virus outbreak has tapered off.

The Public Health Agency of Canada (PHAC) and Health Canada, with the collaboration of provinces and territories, the Canadian Paediatric Society and a network of researchers are actively monitoring adverse events following immunization to the H1N1 flu vaccine in Canada.

Bi-weekly and cumulative number of deaths due to Pandemic (H1N1) 2009, by province/territory, Canada, as of 21 January, 2010

This travel health notice is being provided by the Public Health Agency of Canada (PHAC) in response to the outbreak of H1N1 flu virus. This document has been developed to protect the health of Canadian travellers. This travel health notice is based on current available scientific information about the H1N1 influenza virus, and is subject to review and change as new information becomes available.

The process to establish and implement national goals and recommendations for vaccine preventable diseases in Canada under the national immunization strategy; Summary of the outcomes from the national consensus conference for vaccine-preventable diseases in Canada, Quebec, Quebec, june 12-14, 2005; Initial health screening results for Karen refugees: a retrospective review